Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at SAR 100.5B, ahead of Eli Lilly (SAR 77.4B) and Merck & Co (SAR 68.5B). Figures as of 19 Nov 2026, 13:45 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonSAR 100.5B
- Median
- SAR 1B
- Combined market value
- SAR 34.12T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | SAR 481.5M | SAR 15B | SAR 63.95 | 2.85% down | 49% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | SAR 466.8M | SAR 22.4B | SAR 1,120.46 | 1.67% up | 50% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | SAR 373.8M | SAR 27.8B | SAR 254.28 | 3.25% down | 10% down | ||
| 104 | HaemoneticsHAE · Health Care | SAR 365M | SAR 21B | SAR 460.85 | 1.60% up | 64% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | SAR 270.3M | SAR 28.6B | SAR 82.07 | 3.60% up | 90% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 221.3M | SAR 28B | SAR 356.53 | 0.06% down | 129% up | ||
| 107 | RepligenRGEN · Health Care | SAR 183.4M | SAR 41.4B | SAR 647.69 | 6.47% up | 12% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | SAR 36.2M | SAR 19.6B | SAR 51.65 | 2.82% down | 123% up | ||
| 109 | BillionToOneBLLN · Health Care | SAR 28M | SAR 16.4B | SAR 343.37 | 6.11% down | 4% down | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -SAR 6.1M | SAR 22.9B | SAR 161.71 | 0.28% up | 13% up | ||
| 111 | BrukerBRKR · Health Care | -SAR 32.3M | SAR 36.2B | SAR 237.29 | 3.10% up | 44% up | ||
| 112 | RadNetRDNT · Health Care | -SAR 70M | SAR 21.2B | SAR 269.40 | 4.14% down | 9% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -SAR 87.6M | SAR 22.6B | SAR 346.93 | 0.59% up | 34% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -SAR 95.8M | SAR 18.1B | SAR 188.45 | 1.68% down | 45% up | ||
| 115 | 10x GenomicsTXG · Health Care | -SAR 163.3M | SAR 28.2B | SAR 214.07 | 1.37% up | 247% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -SAR 223.2M | SAR 17.3B | SAR 106.75 | 0.11% down | 74% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -SAR 255.4M | SAR 21B | SAR 73.14 | 2.21% down | 19% down | ||
| 118 | VeradermicsMANE · Health Care | -SAR 262.6M | SAR 19.8B | SAR 468.35 | 0.62% down | 231% up | ||
| 119 | Belite BioBLTE · Health Care | -SAR 291.1M | SAR 23.8B | SAR 586.02 | 0.94% down | 43% up | ||
| 120 | Twist BioscienceTWST · Health Care | -SAR 291.3M | SAR 29.8B | SAR 436.43 | 3.88% up | 346% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -SAR 395.5M | SAR 24.4B | SAR 359.12 | 0.60% down | 255% up | ||
| 122 | HeartflowHTFL · Health Care | -SAR 438.1M | SAR 15.1B | SAR 172.13 | 2.51% down | 66% up | ||
| 123 | ErascaERAS · Health Care | -SAR 467.2M | SAR 18.1B | SAR 51.61 | 0.94% down | 395% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -SAR 488.2M | SAR 31.1B | SAR 476.98 | 2.00% up | 51% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -SAR 541.4M | SAR 59.9B | SAR 1,250.02 | 0.33% up | 106% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -SAR 582.2M | SAR 36.1B | SAR 380.58 | 8.15% up | 332% up | ||
| 127 | CG OncologyCGON · Health Care | -SAR 603.9M | SAR 26.8B | SAR 300.08 | 1.34% up | 97% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -SAR 608.9M | SAR 17.7B | SAR 315.01 | 3.45% down | 108% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -SAR 629.4M | SAR 17B | SAR 155.18 | 1.59% down | 86% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -SAR 687.1M | SAR 26.4B | SAR 502.63 | 1.43% down | 6% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -SAR 689.4M | SAR 15B | SAR 109.23 | 0.88% down | 168% up | ||
| 132 | GlaukosGKOS · Health Care | -SAR 704M | SAR 51.8B | SAR 874.28 | 4.18% down | 145% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -SAR 737.2M | SAR 31B | SAR 446.52 | 2.08% up | 18% up | ||
| 134 | NateraNTRA · Health Care | -SAR 780.8M | SAR 157.5B | SAR 1,085.91 | 0.71% up | 28% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -SAR 862.6M | SAR 24B | SAR 366.89 | 1.04% up | 399% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -SAR 870.2M | SAR 50.1B | SAR 100.15 | 3.29% up | 26% up | ||
| 137 | LivaNovaLIVN · Health Care | -SAR 909.5M | SAR 19.5B | SAR 354.62 | 2.85% up | 77% up | ||
| 138 | Ascendis PharmaASND · Health Care | -SAR 949M | SAR 66.5B | SAR 1,014.01 | 0.32% down | 29% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -SAR 1.1B | SAR 34.7B | SAR 1,493.20 | 5.67% down | 27% down | ||
| 140 | Legend BiotechLEGN · Health Care | -SAR 1.1B | SAR 11.8B | SAR 60.95 | 0.87% up | 41% down | ||
| 141 | Roivant SciencesROIV · Health Care | -SAR 1.1B | SAR 105.3B | SAR 145.28 | 0.05% up | 91% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -SAR 1.1B | SAR 32B | SAR 1,144.77 | 0.04% up | 86% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -SAR 1.2B | SAR 38.8B | SAR 454.36 | 0.32% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -SAR 1.2B | SAR 18.2B | SAR 104.32 | 0.14% down | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -SAR 1.2B | SAR 17.9B | SAR 63.73 | 4.44% down | 8% down | ||
| 146 | ImmunityBioIBRX · Health Care | -SAR 1.3B | SAR 26.7B | SAR 25.13 | 7.03% up | 232% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -SAR 1.3B | SAR 59.7B | SAR 929.39 | 2.93% up | 41% up | ||
| 148 | Bausch + LombBLCO · Health Care | -SAR 1.4B | SAR 28.1B | SAR 78.58 | 0.58% up | 44% up | ||
| 149 | ABIVAXABVX · Health Care | -SAR 1.4B | SAR 27.5B | SAR 314.45 | 2.11% up | 32% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -SAR 1.4B | SAR 22B | SAR 180.05 | 6.48% up | 26% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -SAR 1.4B | SAR 17.1B | SAR 102.74 | 1.59% up | 63% down | ||
| 152 | GRAILGRAL · Health Care | -SAR 1.5B | SAR 17.2B | SAR 382.98 | 3.57% down | 19% up | ||
| 153 | Guardant HealthGH · Health Care | -SAR 1.6B | SAR 73.7B | SAR 544.42 | 1.30% up | 45% up | ||
| 154 | Oscar HealthOSCR · Health Care | -SAR 1.7B | SAR 32.1B | SAR 103.42 | 7.61% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -SAR 1.9B | SAR 25.7B | SAR 124.42 | 0.12% down | 46% up | ||
| 156 | AvantorAVTR · Health Care | -SAR 2B | SAR 39.1B | SAR 57.65 | 1.25% up | 40% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -SAR 2.2B | SAR 14.6B | SAR 150.75 | 0.10% up | 18% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -SAR 2.7B | SAR 57B | SAR 292.62 | 1.58% up | 21% up | ||
| 159 | VaxcytePCVX · Health Care | -SAR 2.9B | SAR 34.7B | SAR 219.51 | 1.48% down | 23% up | ||
| 160 | CytokineticsCYTK · Health Care | -SAR 2.9B | SAR 26.8B | SAR 192.50 | 0.64% down | 19% down | ||
| 161 | TeleflexTFX · Health Care | -SAR 3.4B | SAR 24.7B | SAR 622.10 | 3.95% up | 58% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -SAR 3.6B | SAR 254.9B | SAR 79.78 | 1.71% down | 51% up | ||
| 163 | Baxter InternationalBAX · Health Care | -SAR 3.6B | SAR 50.8B | SAR 98.13 | 1.55% up | 50% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -SAR 4B | SAR 31.5B | SAR 39.39 | 1.59% down | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -SAR 4.2B | SAR 129.7B | SAR 599.48 | 1.76% down | 129% up | ||
| 166 | BioNTechBNTX · Health Care | -SAR 4.7B | SAR 77.4B | SAR 312.31 | 1.89% down | 14% down | ||
| 167 | InsmedINSM · Health Care | -SAR 4.8B | SAR 98.6B | SAR 449.37 | 1.69% down | 40% down | ||
| 168 | ModernaMRNA · Health Care | -SAR 10.6B | SAR 298.7B | SAR 738.16 | 4.84% down | 780% up | ||
| 169 | ViatrisVTRS · Health Care | -SAR 13.2B | SAR 87.2B | SAR 76.07 | 0.83% down | 99% up | ||
| 170 | CenteneCNC · Health Care | -SAR 25B | SAR 125.3B | SAR 253.00 | 7.03% down | 94% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (SAR 100.5B), Eli Lilly (SAR 77.4B) and Merck & Co (SAR 68.5B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 13:45 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of SAR 34.12T as of 19 Nov 2026, 13:45 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.